175 related articles for article (PubMed ID: 23915802)
1. Characterization of biological features of a rat F98 GBM model: a PET-MRI study with [18F]FAZA and [18F]FDG.
Belloli S; Brioschi A; Politi LS; Ronchetti F; Calderoni S; Raccagni I; Pagani A; Monterisi C; Zenga F; Zara G; Fazio F; Mauro A; Moresco RM
Nucl Med Biol; 2013 Aug; 40(6):831-40. PubMed ID: 23915802
[TBL] [Abstract][Full Text] [Related]
2. [
Hovhannisyan N; Fillesoye F; Guillouet S; Ibazizene M; Toutain J; Gourand F; Valable S; Plancoulaine B; Barré L
Theranostics; 2018; 8(16):4563-4573. PubMed ID: 30214639
[TBL] [Abstract][Full Text] [Related]
3. Volumetric analysis of 18F-FDG PET in glioblastoma multiforme: prognostic information and possible role in definition of target volumes in radiation dose escalation.
Tralins KS; Douglas JG; Stelzer KJ; Mankoff DA; Silbergeld DL; Rostomily RC; Hummel S; Scharnhorst J; Krohn KA; Spence AM
J Nucl Med; 2002 Dec; 43(12):1667-73. PubMed ID: 12468518
[TBL] [Abstract][Full Text] [Related]
4. Imaging of hypoxic lesions in patients with gliomas by using positron emission tomography with 1-(2-[18F] fluoro-1-[hydroxymethyl]ethoxy)methyl-2-nitroimidazole, a new 18F-labeled 2-nitroimidazole analog.
Shibahara I; Kumabe T; Kanamori M; Saito R; Sonoda Y; Watanabe M; Iwata R; Higano S; Takanami K; Takai Y; Tominaga T
J Neurosurg; 2010 Aug; 113(2):358-68. PubMed ID: 19895196
[TBL] [Abstract][Full Text] [Related]
5. PET imaging of tumor hypoxia using 18F-fluoroazomycin arabinoside in stage III-IV non-small cell lung cancer patients.
Bollineni VR; Kerner GS; Pruim J; Steenbakkers RJ; Wiegman EM; Koole MJ; de Groot EH; Willemsen AT; Luurtsema G; Widder J; Groen HJ; Langendijk JA
J Nucl Med; 2013 Aug; 54(8):1175-80. PubMed ID: 23753185
[TBL] [Abstract][Full Text] [Related]
6. Optimization of the reference region method for dual pharmacokinetic modeling using Gd-DTPA/MRI and (18) F-FDG/PET.
Poulin É; Lebel R; Croteau É; Blanchette M; Tremblay L; Lecomte R; Bentourkia M; Lepage M
Magn Reson Med; 2015 Feb; 73(2):740-8. PubMed ID: 24604379
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the growth dynamics of angiogenesis-dependent and -independent experimental glioblastomas by multimodal small-animal PET and MRI.
Viel T; Talasila KM; Monfared P; Wang J; Jikeli JF; Waerzeggers Y; Neumaier B; Backes H; Brekka N; Thorsen F; Stieber D; Niclou SP; Winkeler A; Tavitian B; Hoehn M; Bjerkvig R; Miletic H; Jacobs AH
J Nucl Med; 2012 Jul; 53(7):1135-45. PubMed ID: 22689925
[TBL] [Abstract][Full Text] [Related]
8. (18)F-fluoromethylcholine (FCho), (18)F-fluoroethyltyrosine (FET), and (18)F-fluorodeoxyglucose (FDG) for the discrimination between high-grade glioma and radiation necrosis in rats: a PET study.
Bolcaen J; Descamps B; Deblaere K; Boterberg T; De Vos Pharm F; Kalala JP; Van den Broecke C; Decrock E; Leybaert L; Vanhove C; Goethals I
Nucl Med Biol; 2015 Jan; 42(1):38-45. PubMed ID: 25218024
[TBL] [Abstract][Full Text] [Related]
9. Technical feasibility of [
Verhoeven J; Bolcaen J; De Meulenaere V; Kersemans K; Descamps B; Donche S; Van den Broecke C; Boterberg T; Kalala JP; Deblaere K; Vanhove C; De Vos F; Goethals I
Radiat Oncol; 2019 May; 14(1):89. PubMed ID: 31146757
[TBL] [Abstract][Full Text] [Related]
10. Conversion of arterial input functions for dual pharmacokinetic modeling using Gd-DTPA/MRI and 18F-FDG/PET.
Poulin E; Lebel R; Croteau E; Blanchette M; Tremblay L; Lecomte R; Bentourkia M; Lepage M
Magn Reson Med; 2013 Mar; 69(3):781-92. PubMed ID: 22570280
[TBL] [Abstract][Full Text] [Related]
11. Using [¹⁸F]FBAU for imaging brain tumor progression in an F98/tk-luc glioma-bearing rat model.
Chien YC; Chen JC; Lin WC; Ding HJ; Wang HE; Kao CH; Hwang JJ
Oncol Rep; 2014 Aug; 32(2):691-9. PubMed ID: 24926696
[TBL] [Abstract][Full Text] [Related]
12. Positron Emission Tomography (PET) and Pharmacokinetics: Classical Blood Sampling Versus Image-Derived Analysis of [18F]FAZA and [18F]FDG in a Murine Tumor Bearing Model.
Jans HS; Yang XH; Brocks DR; Kumar P; Wuest M; Wiebe LI
J Pharm Pharm Sci; 2018; 21(1s):32s-47s. PubMed ID: 29702045
[TBL] [Abstract][Full Text] [Related]
13. The Added Prognostic Value of Metabolic Tumor Size on FDG-PET at First Suspected Recurrence of Glioblastoma Multiforme.
Chiang GC; Galla N; Ferraro R; Kovanlikaya I
J Neuroimaging; 2017 Mar; 27(2):243-247. PubMed ID: 27515717
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDG PET increases visibility of bone lesions in relapsed multiple myeloma: is this hypoxia-driven?
de Waal EG; Slart RH; Leene MJ; Kluin PM; Vellenga E
Clin Nucl Med; 2015 Apr; 40(4):291-6. PubMed ID: 25546223
[TBL] [Abstract][Full Text] [Related]
15. Standardization and detailed characterization of the syngeneic Fischer/F98 glioma model.
Mathieu D; Lecomte R; Tsanaclis AM; Larouche A; Fortin D
Can J Neurol Sci; 2007 Aug; 34(3):296-306. PubMed ID: 17803026
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the effect of therapy in a rat model of glioblastoma using [18F]FDG and [18F]FCho PET compared to contrast-enhanced MRI.
Bolcaen J; Descamps B; Deblaere K; De Vos F; Boterberg T; Hallaert G; Van den Broecke C; Vanhove C; Goethals I
PLoS One; 2021; 16(3):e0248193. PubMed ID: 33667282
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of early response to SU101 target-based therapy in patients with recurrent supratentorial malignant gliomas using FDG PET and Gd-DTPA MRI.
Vlassenko AG; Thiessen B; Beattie BJ; Malkin MG; Blasberg RG
J Neurooncol; 2000; 46(3):249-59. PubMed ID: 10902856
[TBL] [Abstract][Full Text] [Related]
18. In vivo PET/CT in a human glioblastoma chicken chorioallantoic membrane model: a new tool for oncology and radiotracer development.
Warnock G; Turtoi A; Blomme A; Bretin F; Bahri MA; Lemaire C; Libert LC; Seret AE; Luxen A; Castronovo V; Plenevaux AR
J Nucl Med; 2013 Oct; 54(10):1782-8. PubMed ID: 23970367
[TBL] [Abstract][Full Text] [Related]
19. Fluorine-18-deoxyglucose positron emission tomography/computed tomography with Ki67 and GLUT-1 immunohistochemistry for evaluation of the radiosensitization effect of oleanolic acid on C6 rat gliomas.
Zhang Y; Xu H; Wang H; Yu W; Zhao X; Xue Y
Nucl Med Commun; 2015 Jan; 36(1):21-7. PubMed ID: 25222909
[TBL] [Abstract][Full Text] [Related]
20. A comparison study of dynamic [
Pan Y; Dang H; Zhou H; Fu H; Wu S; Liu H; Zhang J; Wang R; Tian Y; Xu B
J Cancer Res Clin Oncol; 2024 Apr; 150(4):208. PubMed ID: 38647690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
